2Joseph A,Mokbel K.Male breast cancer[J].Int J Fartil Womens Med,2004,49(5):198-199.
3Joshi MG,Lee AK,Loda M,et al.Male breast carcinoma:an evaluation of prognostic factors contributing to a poorer out come[J].Cancer,1996,77(3):490-498.
4Giordano SH,Cohen DS,Buzdar Alsetal.Breast carcinom a in man:a population-based study[J].Cancer,2005,103(2):432-433.
5Movassagh M, Spatz A, Davoust J, et al. Selective accumulation of mature DC-Lamp-dendritic cells in tumor sites is associ ated with efficient T-cell-mediated antitumor response and con trol of metastatic disseminationin melanoma[J]. Cancer Res, 2004,64(6) :2192-2198.
6Taylor RC, Patel A, Panageas KS, et al. Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma[J ]. J Clin Oncol, 2007,25 (7) : 869- 875.
7Pages F,Berger A,Camus M,et al. Effector memory T cells, early metastasis,and survival in colorectal cancer[J]. N Engl J Med,2005,353(25) :2654- 2666.
8Krause W. Male breast cancer-an andrological disease.- risk factors and diagnosis[J]. Andrologia, 2004,36 (6) : 346-354.
9Basham VM, Lipscombe JM, Ward JM, et al. BRCA1 and BRCA2 mutations in a population-based study of nude breast cancer[J]. Breast Cancer Res, 2002,4(1): R2.
10Grevans D, Susnerwala I, Dawson J, et al. Risk of breast cancer in male BRCA2 carriers[J]. J Med Genet, 2010, 47: 710-711.
